Hepatology

A newly developed prognostic model predicts liver cancer risk in patients with hepatitis B without cirrhosis, identifying a nonlinear relationship between viral load and cancer risk

Researchers have revealed that a previous paternal hepatitis B virus infection before conception is associated with an increased risk of congenital heart diseases in offspring.

The Baveno VI criteria, combining liver stiffness and platelet count, offer a noninvasive, cost-effective approach to identifying high-risk varices in patients with cirrhosis

The latest clinical guidelines for diagnosing and managing metabolic dysfunction-associated steatotic liver disease, previously known as NAFLD

A novel automated speech analysis platform has been developed to test for minimal hepatic encephalopathy (HE) and to predict overt HE in patients with cirrhosis. 

Researchers have discovered that the use of glucagon-like peptide 1 receptor agonists in patients with MASLD is linked to a significant reduction in the risk of developing cirrhosis and its complications. 

Declines in serum hepatitis B virus RNA during the first and second year of treatment with nucleoside analogues could be indicators of reduced risk for hepatocellular carcinoma.

A recent study has highlighted a concerning gender disparity in access to liver transplants showing that women on the liver transplant waiting list are less likely to undergo a transplant